216 related articles for article (PubMed ID: 24750373)
1. Racial disparities in cardiovascular risk factor control in an underinsured population with Type 2 diabetes.
Wang Y; Katzmarzyk PT; Horswell R; Zhao W; Li W; Johnson J; Ryan DH; Hu G
Diabet Med; 2014 Oct; 31(10):1230-6. PubMed ID: 24750373
[TBL] [Abstract][Full Text] [Related]
2. The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial.
Saremi A; Schwenke DC; Bahn G; Ge L; Emanuele N; Reaven PD;
Metabolism; 2015 Feb; 64(2):218-25. PubMed ID: 25456099
[TBL] [Abstract][Full Text] [Related]
3. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
[TBL] [Abstract][Full Text] [Related]
4. The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study.
Freedman BI; Hsu FC; Langefeld CD; Rich SS; Herrington DM; Carr JJ; Xu J; Bowden DW; Wagenknecht LE
Diabetologia; 2005 Dec; 48(12):2511-8. PubMed ID: 16261310
[TBL] [Abstract][Full Text] [Related]
5. Egg consumption and cardiovascular disease according to diabetic status: The PREDIMED study.
Díez-Espino J; Basterra-Gortari FJ; Salas-Salvadó J; Buil-Cosiales P; Corella D; Schröder H; Estruch R; Ros E; Gómez-Gracia E; Arós F; Fiol M; Lapetra J; Serra-Majem L; Pintó X; Babio N; Quiles L; Fito M; Marti A; Toledo E;
Clin Nutr; 2017 Aug; 36(4):1015-1021. PubMed ID: 27448949
[TBL] [Abstract][Full Text] [Related]
6. Prediction of treatment response in patients with newly diagnosed type 2 diabetes: the Skaraborg diabetes register.
Pikkemaat M; Melander O; Hjerpe P; Bengtsson Boström K
J Diabetes Complications; 2017 May; 31(5):854-858. PubMed ID: 28319005
[TBL] [Abstract][Full Text] [Related]
7. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.
Simpson SH; Lier DA; Majumdar SR; Tsuyuki RT; Lewanczuk RZ; Spooner R; Johnson JA
Diabet Med; 2015 Jul; 32(7):899-906. PubMed ID: 25594919
[TBL] [Abstract][Full Text] [Related]
9. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.
Lafata JE; Karter AJ; O'Connor PJ; Morris H; Schmittdiel JA; Ratliff S; Newton KM; Raebel MA; Pathak RD; Thomas A; Butler MG; Reynolds K; Waitzfelder B; Steiner JF
J Gen Intern Med; 2016 Feb; 31(2):188-195. PubMed ID: 26282954
[TBL] [Abstract][Full Text] [Related]
10. HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes.
Obermannova B; Petruzelkova L; Sulakova T; Sumnik Z
Pediatr Diabetes; 2017 Jun; 18(4):304-310. PubMed ID: 27075550
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in diabetic complications in an underinsured population.
Wang Y; Katzmarzyk PT; Horswell R; Li W; Xiao K; Besse J; Xie W; Johnson J; Heymsfield S; Ryan DH; Hu G
J Clin Endocrinol Metab; 2012 Dec; 97(12):4446-53. PubMed ID: 22977274
[TBL] [Abstract][Full Text] [Related]
12. Dapagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in people with type 2 diabetes (CVD-REAL Nordic) when compared with dipeptidyl peptidase-4 inhibitor therapy: A multinational observational study.
Persson F; Nyström T; Jørgensen ME; Carstensen B; Gulseth HL; Thuresson M; Fenici P; Nathanson D; Eriksson JW; Norhammar A; Bodegard J; Birkeland KI
Diabetes Obes Metab; 2018 Feb; 20(2):344-351. PubMed ID: 28771923
[TBL] [Abstract][Full Text] [Related]
13. Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease.
Boronat M; García-Cantón C; López-Ríos L; Quevedo V; Lorenzo DL; Batista F; Riaño M; Nóvoa FJ
Diab Vasc Dis Res; 2014 Jan; 11(1):53-9. PubMed ID: 24254975
[TBL] [Abstract][Full Text] [Related]
14. Heart matters: Gender and racial differences cardiovascular disease risk factor control among veterans.
Goldstein KM; Melnyk SD; Zullig LL; Stechuchak KM; Oddone E; Bastian LA; Rakley S; Olsen MK; Bosworth HB
Womens Health Issues; 2014; 24(5):477-83. PubMed ID: 25213741
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study.
Parrinello CM; Rastegar I; Godino JG; Miedema MD; Matsushita K; Selvin E
Diabetes Care; 2015 Jul; 38(7):1290-8. PubMed ID: 25852205
[TBL] [Abstract][Full Text] [Related]
16. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
[TBL] [Abstract][Full Text] [Related]
17. Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
Laffin LJ; Bakris GL
Diabetes Obes Metab; 2018 Jun; 20(6):1335-1336. PubMed ID: 29424470
[TBL] [Abstract][Full Text] [Related]
18. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
[TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.
Wendel CS; Shah JH; Duckworth WC; Hoffman RM; Mohler MJ; Murata GH
BMC Health Serv Res; 2006 May; 6():58. PubMed ID: 16716235
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular Risk Factor Status in Hospitalized Patients With Type 2 Diabetes in China.
Yang X; Liu Q; Fan Y; Ding L; Wang R; Hu G; Liu M
Front Endocrinol (Lausanne); 2021; 12():664183. PubMed ID: 34367063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
